Satori Pharmaceuticals

About:

Satori Pharmaceuticals develops disease-modifying therapies for alzheimer's, parkinson's and other neurodegenerative disorders.

Website: http://www.satoripharma.com

Twitter/X: meetornext

Top Investors: New Enterprise Associates, PureTech Health, InterWest Partners, Prospect Venture Partners

Description:

Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

Total Funding Amount:

$47.3M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2005-01-01

Founders:

Mark Findeis

Number of Employees:

11-50

Last Funding Date:

2012-02-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai